|
C14ORF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56120000005533E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24560000003271E-06 |
| Normal-vs-Stage2 |
2.38429999965817E-07 |
| Normal-vs-Stage3 |
1.73030999999213E-05 |
| Normal-vs-Stage4 |
7.40149999955975E-07 |
| Stage1-vs-Stage2 |
2.356400E-01 |
| Stage1-vs-Stage3 |
9.454800E-01 |
| Stage1-vs-Stage4 |
2.314000E-01 |
| Stage2-vs-Stage3 |
4.734200E-01 |
| Stage2-vs-Stage4 |
7.579800E-01 |
| Stage3-vs-Stage4 |
4.949000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.10009999998439E-06 |
| Normal-vs-AfricanAmerican |
1.96169999999718E-06 |
| Normal-vs-Asian |
2.07839999988302E-07 |
| Caucasian-vs-AfricanAmerican |
8.892400E-01 |
| Caucasian-vs-Asian |
1.099430E-01 |
| AfricanAmerican-vs-Asian |
1.311610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.25350000005298E-07 |
| Normal-vs-Female |
3.77639999999957E-05 |
| Male-vs-Female |
5.718000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.79340000025807E-07 |
| Normal-vs-Extreme_Weight |
1.09339999998515E-06 |
| Normal-vs-Obese |
8.04810000000211E-05 |
| Normal-vs-Extreme_Obese |
1.15500000008595E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.251800E-01 |
| Normal_Weight-vs-Obese |
5.698500E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.291600E-01 |
| Extreme_Weight-vs-Obese |
1.200590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.248400E-02 |
| Obese-vs-Extreme_Obese |
7.780500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.746400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.49259999995921E-06 |
| Normal-vs-Age(61-80Yrs) |
4.64820000045663E-07 |
| Normal-vs-Age(81-100Yrs) |
1.35649999999377E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.335400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.305810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.693800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.458400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.163400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.862600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.71559999998061E-06 |
| Normal-VS-Type2 PRCC |
3.68820000096193E-08 |
| Normal-VS-KIRP CIMP |
1.213190E-01 |
| Normal-VS-Unclassified PRCC |
3.1369999999864E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.341730E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.486000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.346600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.505500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.012200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.107900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.75929999959956E-08 |
| Normal-vs-N1 |
9.97480000000106E-05 |
| Normal-vs-N2 |
4.986300E-02 |
| N0-vs-N1 |
1.276560E-01 |
| N0-vs-N2 |
2.020400E-01 |
| N1-vs-N2 |
9.606800E-01 |
|
|
